62910-48-9

Usage

Uses

Used in Pharmaceutical Industry:
4-aminomethylphenylacetic acid ethyl ester is used as an intermediate in the synthesis of various pharmaceuticals for its role in creating essential medications.
Used in Agrochemical Industry:
4-aminomethylphenylacetic acid ethyl ester is also utilized as an intermediate in the production of agrochemicals, contributing to the development of agricultural products.
Used in Therapeutic Applications:
4-aminomethylphenylacetic acid ethyl ester is used as a neurotransmitter precursor, indicating its potential in the treatment of neurological conditions and disorders.

Upstream product

• 1528-41-2 ethyl 4-cyanophenylacetate 

Downstream Products

• 62910-18-3 4-(2-ethoxy-5-chlorobenzamidomethyl)-phenylacetic acid 
• 62910-17-2 4-(5-chloro-2-methoxybenzamidomethyl)-phenylacetic acid 
• 1200-05-1 2-(4-(aminomethyl)phenyl)acetic acid 
• 62910-19-4 4-(2-butoxy-5-chlorobenzamidomethyl)-phenylacetic acid 

Relevant academic research and scientific papers

Novel thiophene derivatives, their process of preparation and the pharmaceutical compositions which comprise them

A compound of formula (I) selected from: wherein: X represents oxygen or sulphur, Y represents oxygen, —NH— or —N(C1-C6)alkyl-, Ra represents hydrogen, halogen, (C1-C3)alkyl, hydroxyl or (C1-C3)alkoxy, Rb represents hydrogen, halogen or (C1-C3)alkyl, A represents phenyl, pyridyl, (C5-C6)cycloalkyl or (C5-C6)cycloalkenyl, R1 and R2 each represent a group selected from hydrogen, halogen, cyano, nitro, haloalkyl, haloalkoxy, alkyl, alkenyl, alkynyl, —OR4, —NR4R5, —S(O)nR4, —C(O)R4, —CO2R4, —O—C(O)R4, —C(O)NR4R5, —NR5—C(O)R4, —NR5—SO2R4, -T-CN, -T-OR4, -T-OCF3, -T- NR4R5, -T-S(O)nR4, -T-C(O)R4, -T-CO2R4, -T-O—C(O)R4, -T-C(O)NR4R5, -T-NR4—C(O)R5, -T-NR4—SO2R5, —R6 and -T-R6 in which n, T, R4, R5 and R6 are as defined in the description, R3 represents an —R7 or —U—R11 group in which R7 represents hydrogen, alkyl, aryl, cycloalkyl or heterocycle, U represents a linear or branched alkylene chain and R11 is defined in the description, their optical isomers or their addition salts with a pharmaceutically acceptable acid or base, and their use as inhibitor of metalloproteinase and more specifically of metalloproteinase-12.

NOVEL PYRIMIDINE-4,6-DICARBOXAMIDES FOR THE SELECTIVE INHIBITION OF COLLAGENASES

Pyrimidine-4,6-dicarboxamides of formula (I), are suitable for the selective inhibition of collagenase (MMP 13). The pyrimidine-4,6-dicarboxamides can thus be used for the treatment of degenerative joint diseases.